Are there scenarios in which you would add nimotuzumab to cisplatin based concurrent chemoRT to treat locally advanced head and neck cancer?

Personally, I would not use the combination of nimotuzumab and cisplatin with RT since it is not FDA approved in the United States. There is data to support the combination might be beneficial for patients with locally advanced SCCHN. However, the drug is not commercially available, and most insuran...